Rubric Capital Management LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $6.08 Billion distributed in 72 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Teva Pharmaceutical Industries LTD with a value of $498M, Golar Lng LTD with a value of $371M, Roivant Sciences Ltd. with a value of $303M, Transalta Corp with a value of $218M, and Arcutis Biotherapeutics, Inc. with a value of $203M.

Examining the 13F form we can see an increase of $1.74B in the current position value, from $4.34B to 6.08B.

Rubric Capital Management LP is based out at New York, NY

Below you can find more details about Rubric Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $6.08 Billion
Healthcare: $2.36 Billion
ETFs: $1.42 Billion
Energy: $484 Million
Industrials: $461 Million
Utilities: $384 Million
Communication Services: $241 Million
Technology: $219 Million
Financial Services: $174 Million
Other: $347 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 72
  • Current Value $6.08 Billion
  • Prior Value $4.34 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 16 stocks
  • Additional Purchases 19 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.